Announcements
The latest Impact Factors have been released and are updated in our site!Not a Current Subscriber?
Subscribe Now
5819 Journals
4824 Congresses
10600+ Unique Records
RSC Medicinal Chemistry
Title Abbreviation
RSC Med Chem
Electronic ISSN
2632-8682
Therapeutic Area
Readership
Academicians, Bio Chemists, Chemical Biologists, Chemists, Computational Chemists, Medicinal Chemists, Molecular Biologists, Nanotechnologists, Pharmaceutical Scientistists, Pharmacologists
Scope
Research articles published in this journal must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field.
Examples of areas within the journal's scope are: Design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities. To be suitable for publication these must exhibit significant potential as new pharmacological agents, tools, probes or potential drugs; Modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value, for example, the identification of a new target or mode of action for a known agent. Routine modifications with minimal or no improvement are not suitable for RSC Medicinal Chemistry. Novel methodologies and technologies in the broader chemical and biological sciences (for example, enabling synthetic chemistry, chemical biology, -omics sciences, nanoscience) with application to drug discovery, target identification or elucidation of the mechanism of action. Biological studies should present sufficient innovation with respect to the chemistry; Computational studies are welcome where they significantly advance medicinal chemistry knowledge. Studies that use established computational methods should include an original prediction and be accompanied by new experimental data which validates the prediction made. Studies that report novel computational methodology must demonstrate its use in medicinal chemistry through comparison with experimental data. Computational research that does not clearly relate the results obtained to experimental data or that has no demonstrated utility (or where the utility is unlikely to advance the field significantly) is not suitable for RSC Medicinal Chemistry. Docking studies presented without experimental data are not suitable for publication in the journal; Studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; Studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence;
Studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors. Those that focus solely on formulations of known drugs are not suitable for publication in RSC Medicinal Chemistry.
Sponsoring Association(s)
Royal Society of Chemistry (RSC)
Publisher Name
Royal Society of Chemistry (RSC)
Testimonials
| "PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection." | |
|
– Kait G
Editorial-Project Editor
|
|
| "It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly" | |
|
– Michael K.
Medical Communications Leader
|
|
| "…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research." | |
|
- Weill Cornell Medical Library
|
|
Journals ● Congresses ● Associations
Privacy Policy ● Terms of Service ● Glossary ● Contact Us
Privacy Policy ● Terms of Service ● Glossary ● Contact Us
Copyright ©2025 ICON plc ● All Rights Reserved ● Version 13.0
